Using highly sensitive culturomics, TMP1 was found to be enriched in stool samples from RCC and melanoma anti‐PD1 recipients experiencing longer OS, providing (to our knowledge) the first clinical evidence supporting this phenomenon [113]. Here, PDCD1 is linked to renal cell carcinoma.